Pharmafile Logo
Pharmafocus logo
Advanced Search

Business Services

Pharmaceutical Business Services – News, analysis and company profiles

Showing 15 posts of 2453 posts found.

top_10_image_2_1

Top Ten most popular articles on Pharmafile.com this week

May 1, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Gilead, UK, coronaviurs

The search for a COVID-19 treatment has ramped up this week, with two new studies detailing the efficacy of Gilead’s …
News
judge-gavel-1461966002dbr

Teva’s cancer drug Bendeka protected from generics until 2031, judge rules

April 30, 2020 Business Services Bendeka, Teva, Teva and Eagle

A US federal judge has ruled that generic versions of the cancer treatment Bendeka infringe on four separate patents, and …
News
desantis

More than half of US states will relax lockdowns by the end of the week

April 30, 2020 Business Services COVID-19, Lockdown, coronavirus, quaratine

Nearly half of US states will have their ‘stay-at-home’ orders expire this week, paving the way for much of the …
News
facemask

Men most likely to exhibit the worst COVID-19 symptoms, according to a new study

April 30, 2020 Business Services COVID-19, coronavirus

Research into coronavirus cases in Shenzhen, China found that men were 2.5 times as likely to exhibit severe symptoms. The …
News
pharmafocus_may_2020_cover

The May 2020 issue of Pharmafocus is available to read free online now!

April 28, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus, pharma

The latest monthly edition of Pharmafocus, the May 2020 issue, is available to read for free online now!
News

Reinventing the value equation

April 27, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Drug pricing, feature, real world data, real world evidence, real-world data, real-world evidence

There is a duty to ensure access to innovative treatments for patients with unmet need, but a health service gatekeeper …
Feature
aloe-vera-2417091_960_720

European Medicines Agency’s review of Picato finds its risks outweigh its benefits

April 24, 2020 Business Services, Medical Communications, Sales and Marketing

The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) has confirmed that the risks from using Picato are too high …
News
social_distancing

Socially disruptive measures will exist in Britain until at least the end of the year

April 23, 2020 Business Services Britian COVID-19, COVID-19, coronavirus

England’s Chief Medical Officer Chris Whitty has said that the UK will have to live with some form of socially …
News
fda

Cheaper Canadian drug imports continue to be seized by the FDA

April 23, 2020 Business Services COVID-19, Canada, FDA, coronavirus, insulin

Seizures of Canadian drugs being sent to American patients have been stepped up by the FDA. This is according to …
News
department_of_health__human_services_-_stierch

BARDA director abruptly leaves post, claims he was ousted over pushback to hydroxychloroquine

April 23, 2020 Business Services COVID-19, HHS, coronavirus

Rick Bright has claimed that he has been forced out of his position as the Director of the US Biomedical …
News
ny

How the intended role of generic medicines is being undermined in America

April 20, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Drug pricing, US, feature, generic medicines, generics

The introduction of a generic medicine should, in theory, incentivise companies to lower the price of the original drug, creating healthy …
Feature
800px-rhesus_macaque_macaca_mulatta_in_kinnarsani_ws_ap_w_img_5792

Gilead’s remdesivir significantly reduces COVID-19 symptoms in rhesus monkeys in NIH trial

April 20, 2020 Business Services, Medical Communications, Sales and Marketing COVID-19, Gilead, National Institutes of Health, coronavirus, remdesivir

A study from the National Institutes of Health has shed more light on the efficacy of Gilead’s promising antiviral therapy …
News
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

April 17, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus, top 10

Hydroxychloroquine dominates the news as the potential COVID-19 treatment has gone through various trials. A Chinese study showed that the …
News
aripiprazoleabilify

Clinical trial suggests new schizophrenia drug could reduce symptoms

April 16, 2020 Business Services D2, clinical trials, schizophrenia

Results from a newly published clinical trial suggest that a new compound could treat a broad range of schizophrenia symptoms. …
News
poshoo

New Chinese study shows Hydroxychloroquine does not speed up COVID-19 recovery

April 16, 2020 Business Services COVID-19, chloroquine, coronavirus, hydroxychloroquine

The anti-malaria drug hydroxychloroquine does not speed up recovery from COVID-19, according to a new Chinese study. The study was …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025